Related content

Survivin, Ki67 and tumor grade as predictors of response to docetaxelbased neoadjuvant chemotherapy in locally advanced breast cancer

By              

Molecular and Clinical Oncology, Vol. 1, Iss. 5, 2013-01 ,pp. : 839-844

Spandidos Publications

Access to resources Recommend Favorite

Serum thymidine kinase 1 levels predict cancerfree survival following neoadjuvant, surgical and adjuvant treatment of patients with locally advanced breast cancer

By                    

Molecular and Clinical Oncology, Vol. 1, Iss. 5, 2013-01 ,pp. : 894-902

Spandidos Publications

Access to resources Recommend Favorite

Weekly administration of paclitaxel and carboplatin with concurrent thoracic radiation in previously untreated elderly patients with locally advanced nonsmallcell lung cancer: A case series of 20 patients

By                                  

Molecular and Clinical Oncology, Vol. 2, Iss. 3, 2014-01 ,pp. : 454-460

Spandidos Publications

Access to resources Recommend Favorite

Efficacy of chemotherapy plus gefitinib treatment in advanced nonsmallcell lung cancer patients following acquired resistance to gefitinib

By    

Molecular and Clinical Oncology, Vol. 1, Iss. 5, 2013-01 ,pp. : 875-878

Spandidos Publications

Access to resources Recommend Favorite

Metronomic chemotherapy for metastatic breast cancer to prolong time to treatment failure to 12 months or more

By Kontani  

Molecular and Clinical Oncology, Vol. 1, Iss. 2, 2013-01 ,pp. : 225-230

Spandidos Publications

Access to resources Recommend Favorite